Expressions of ER, PR, HER-2, COX-2, and VEGF in Primary and Relapsed/Metastatic Breast Cancers

Hepatobiliary Cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben‐Josef et al. · Journal of the National Comprehensive Cancer Network · 2009 · 2.3K citations · Full text

Medicine, Oncology, Pathology +14

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

D Forman, Heather Bryant, J. Butler et al. · The Lancet · 2010 · 1.1K citations · Full text

Medicine, Biostatistics, Oncology +17

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

Ari Ristimäki, Anna Sivula, Johan Lundin et al. · PubMed · 2002 · 787 citations

Medicine, Cancer Biology, Oncology +16

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization.

D O Toft, J Górski · Proceedings of the National Academy of Sciences · 1966 · 679 citations · Full text

Life Sciences, Endocrinology, Physiology +16